139 related items for PubMed ID: 22198072
1. Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.
Fujinaga S, Hirano D, Murakami H, Ohtomo Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2012 Apr; 27(4):671-4. PubMed ID: 22198072
[Abstract] [Full Text] [Related]
2. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K.
Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
[Abstract] [Full Text] [Related]
3. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S.
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[Abstract] [Full Text] [Related]
4. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE.
J Am Soc Nephrol; 1996 Apr; 7(4):543-9. PubMed ID: 8724887
[Abstract] [Full Text] [Related]
5. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S, Imai N, Sueki S, Matsui K, Tominaga N, Sakurada T, Yasuda T, Kimura K, Shibagaki Y.
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[Abstract] [Full Text] [Related]
6. Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years.
Kranz B, Vester U, Büscher R, Wingen AM, Hoyer PF.
Pediatr Nephrol; 2008 Apr; 23(4):581-6. PubMed ID: 18197423
[Abstract] [Full Text] [Related]
7. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y.
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[Abstract] [Full Text] [Related]
8. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.
Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G.
Pediatr Nephrol; 2005 Jan; 20(1):25-9. PubMed ID: 15602664
[Abstract] [Full Text] [Related]
9. Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome.
Fujinaga S, Nishino T, Urushihara Y.
Clin Exp Nephrol; 2021 Feb; 25(2):213-214. PubMed ID: 33025235
[No Abstract] [Full Text] [Related]
10. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.
Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F.
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1409-16. PubMed ID: 19628686
[Abstract] [Full Text] [Related]
11. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.
Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N.
Kidney Int; 2002 May; 61(5):1801-5. PubMed ID: 11967030
[Abstract] [Full Text] [Related]
12. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2010 Mar; 25(3):539-44. PubMed ID: 20049616
[Abstract] [Full Text] [Related]
13. Renal biopsy findings in children receiving long-term treatment with cyclosporine a given as a single daily dose.
Tanaka H, Tsugawa K, Suzuki K, Ito E.
Tohoku J Exp Med; 2006 Jul; 209(3):191-6. PubMed ID: 16778365
[Abstract] [Full Text] [Related]
14. Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome.
Woo KT, Chew ST, Vathsala A, Chiang GS.
Ann Acad Med Singap; 2001 Jul; 30(4):430-5. PubMed ID: 11503553
[Abstract] [Full Text] [Related]
15. Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.
Suzuki K, Oki E, Tsuruga K, Aizawa-Yashiro T, Ito E, Tanaka H.
Tohoku J Exp Med; 2010 Mar; 220(3):183-6. PubMed ID: 20208412
[Abstract] [Full Text] [Related]
16. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[Abstract] [Full Text] [Related]
17. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
Sabry A, El-Husseini A, El-Dahshan K, Sobh M.
Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
[Abstract] [Full Text] [Related]
18. Long-term clinical and pathological effects of cyclosporin in children with nephrosis.
Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R.
Pediatr Nephrol; 2000 Mar; 14(3):214-7. PubMed ID: 10752760
[Abstract] [Full Text] [Related]
19. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
Wyszyńska T, Ksiazek J, Wieteska-Klimczak A, Gorzkowska-Paczwa M, Dorywalski T, Tysarowska A.
Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
[Abstract] [Full Text] [Related]
20. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
